EditorialKommentar
A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
NEJM Evidence · 2023
DOI: 10.1056/evide2200306 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, 2023. Verfasst von Hershel Raff und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee. Hauptthemen laut MEDLINE: Cortisone, Adrenal Insufficiency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
CortisoneAdrenal InsufficiencyHumansHydrocortisoneAdrenocorticotropic HormoneGlucocorticoids
Substanzen
HydrocortisoneCortisoneAdrenocorticotropic HormoneGlucocorticoids
Autor:innen und Institutionen
- Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee.
- Endocrine Research Laboratory, Aurora St. Luke's Medical Center, Milwaukee.
Zitieren
APA
Raff, H., & Zhang, C. D. (2023). A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evidence. https://doi.org/10.1056/evide2200306
Vancouver
Raff H, Zhang CD. A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evidence. 2023. doi:10.1056/evide2200306
BibTeX
@article{Raff2023,
author = {Raff, Hershel and Zhang, Catherine D},
title = {A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency},
journal = {NEJM Evidence},
year = {2023},
doi = {10.1056/evide2200306}
}
EUVIMED